These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6600908)

  • 1. Susceptibility of Pseudomonas paucimobilis to 24 antimicrobial agents.
    Smalley DL; Hansen VR; Baselski VS
    Antimicrob Agents Chemother; 1983 Jan; 23(1):161-2. PubMed ID: 6600908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Prince AS; Neu HC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of community hospital blood culture isolates of gram-negative bacilli.
    Gordon RC; Tack KJ; Haddy RI; Fechner L; Wofford R
    Chemotherapy; 1984; 30(1):40-3. PubMed ID: 6420120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibilities of 45 clinical isolates of Proteus penneri.
    Fuksa M; Krajden S; Lee A
    Antimicrob Agents Chemother; 1984 Sep; 26(3):419-20. PubMed ID: 6508270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance of enterobacteria and Pseudomonas to old and new antimicrobial agents].
    Guiscafré H; Leaños B; Solórzano F; Zúñiga V
    Bol Med Hosp Infant Mex; 1989 Mar; 46(3):163-70. PubMed ID: 2713068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance of Acinetobacter calcoaceticus strains isolated from patients treated in intensive care units.
    Kiss L; Leskó T; Széll M
    Acta Microbiol Immunol Hung; 1995; 42(4):381-7. PubMed ID: 8689090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Infection; 1982; 10 Suppl 3():S257-61. PubMed ID: 6818158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H; Peladan F; Zinsius M
    Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Pseudomonas mallei to antimicrobial agents.
    Al-Izzi SA; Al-Bassam LS
    Comp Immunol Microbiol Infect Dis; 1989; 12(1-2):5-8. PubMed ID: 2776405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics.
    Santos Ferreira MO; Canica MM; Bacelar MJ
    J Int Med Res; 1985; 13(5):270-5. PubMed ID: 3902532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
    Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
    Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
    Tweardy DJ; Jacobs MR; Speck WT
    J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.